Stock INCR INTERCURE LTD.
Add to a list
To use this feature you must be a member
Log inSign up

InterCure Ltd. Stock

Equities

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 07:24:53 2024-04-24 am EDT 		5-day change 1st Jan Change
992.3 ILa +5.01% Intraday chart for InterCure Ltd. +9.19% +114.27%
Apr. 01 InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023 CI
Mar. 22 InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months CI

Financials

Sales 2021 219.68 82.97K Sales 2022 388.68 147K Capitalization 551M 208B
Net income 2021 4M 1.51B Net income 2022 44M 16.62B EV / Sales 2021 3,844,919 x
Net cash position 2021 87.64M 33.1B Net Debt 2022 22.37M 8.45B EV / Sales 2022 1,473,908 x
P/E ratio 2021
207 x
P/E ratio 2022
12.2 x
Employees 370
Yield 2021 *
-
Yield 2022
-
Free-Float 64.2%
More Fundamentals * Assessed data

Chart InterCure Ltd.

Dynamic Chart

Latest news about InterCure Ltd.

InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023 CI
InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months CI
InterCure Ltd. Announces Resignation of Rami Levy as Chief of Operations CI
InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million. CI
InterCure Ltd.(TASE:INCR) dropped from S&P Global BMI Index CI
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Intercure to Delist Its Shares From the Toronto Stock Exchange MT
InterCure Provides Update About Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger MT
Transcript : InterCure Ltd., 2022 Earnings Call, Apr 04, 2023
InterCure Ltd. entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd. CI
InterCure to Launch Trading on Nasdaq Wednesday MT
InterCure Ltd. Announces Earnings Results for the Second Quarter Ended June 30, 2021 CI
InterCure Provided Update on Its NASDAQ Listing MT
InterCure Ltd signed a Letter of Intent to acquire Cann Pharmaceutical Ltd. for $35 million. CI
InterCure : Israel's Canndoc signs cannabis import-export deal with Tilray RE
More news

Latest transcript on InterCure Ltd.

Logo InterCure Ltd.
InterCure Ltd., 2022 Earnings Call, Apr 04, 2023
More transcripts

Press releases InterCure Ltd.

InterCure : Preliminary results for the full year of 2023 PU
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million BU
InterCure : Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million - Form 6-K PU
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint BU
InterCure Provides an Update Regarding Nir Oz Facility AQ
More press releases

News in other languages on InterCure Ltd.

Tilray, Inc. : première exportation de cannabis vers Israël
More news

Quotes and Performance

1 day+5.01%
1 week+9.19%
Current month+0.54%
1 month+21.47%
3 months+96.07%
6 months+117.09%
Current year+114.27%
More quotes

Highs and lows

1 week
900.00
Extreme 900
997.00
1 month
850.00
Extreme 850
1 049.00
Current year
440.00
Extreme 440
1 049.00
1 year
395.00
Extreme 395
1 049.00
3 years
395.00
Extreme 395
2 845.00
5 years
395.00
Extreme 395
4 827.45
10 years
124.58
Extreme 124.5792
6 317.95
More quotes

Managers and Directors - InterCure Ltd.

Managers TitleAgeSince
Alexander Rabinovitch CEO
 Chief Executive Officer 53 18-09-30
Amos Cohen DFI
 Director of Finance/CFO 45 20-02-29
Boaz Lahav SAM
 Sales & Marketing - 22-10-31
Members of the board TitleAgeSince
Ehud Barak CHM
 Chairman 81 18-08-31
Alexander Rabinovitch CEO
 Chief Executive Officer 53 18-09-30
Alon Shmuel Granot BRD
 Director/Board Member 62 20-10-31
More insiders

ETFs positioned on InterCure Ltd.

Name Weight AuM 1st Jan change Investor Rating
ADVISORSHARES POSEIDON DYNAMIC CANNABIS ETF - USD ETF AdvisorShares Poseidon Dynamic Cannabis ETF - USD
13.29% 3 M€ -35.65% -
RIZE MEDICAL CANNABIS AND LIFE SCIENCES UCITS ETF ACC - USD ETF Rize Medical Cannabis and Life Sciences UCITS ETF Acc - USD
0.13% 13 M€ -.--%
More ETFs positioned on InterCure Ltd.

Quotes

Date Price Change Volume
24-04-24 992.3 +5.01% 104,493
24-04-21 945 +1.61% 260,483
24-04-18 930 +2.42% 286,254
24-04-17 908 -0.09% 125,555
24-04-16 908.8 -2.28% 56,270

Delayed Quote TEL AVIV STOCK EXCHANGE, April 24, 2024 at 07:24 am EDT

More quotes

Company Profile

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Sector
Healthcare Facilities & Services
Calendar
2024-05-12 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Farming

1st Jan change Capi.
INTERCURE LTD. Stock InterCure Ltd.
+114.27% 114M
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+31.96% 291M
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+38.27% 274M
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+54.65% 203M
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+48.33% 133M
THE CANNABIST COMPANY HOLDINGS INC. Stock The Cannabist Company Holdings Inc.
-39.97% 122M
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-28.57% 121M
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
-23.08% 70.21M
GOLD FLORA CORPORATION Stock Gold Flora Corporation
+26.88% 60.11M
Medical Farming
  1. Stock Market
  2. Equities
  3. INCR Stock